HCM
AMAG

Highbridge Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Highbridge Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-25,900
Closed -$477K – 1876
2017
Q2 		$477K Buy
+25,900
New +$513K 0.01% 770
2016
Q4 		– Sell
-8,900
Closed -$218K – 1718
2016
Q3 		$218K Buy
+8,900
New +$222K ﹤0.01% 1150
2016
Q1 		– Sell
-11,500
Closed -$347K – 1933
2015
Q4 		$347K Buy
+11,500
New +$372K 0.01% 1133

Other funds holding AMAG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Highbridge Capital Management's AMAG Position: Q1 2018 in Review

Highbridge Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2018, closing a stake of 11,842 shares — an estimated $157K sold.

Highbridge Capital Management first reported a position in AMAG in Q4 2014 and held it in 10 quarters. The position peaked at $22.2M in Q2 2015. 170 funds tracked by Wall St. Rank hold AMAG as of Q1 2018.

  • Highbridge Capital Management reported no remaining AMAG Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 11,842 AMAG Pharmaceuticals shares in Q1 2018, an estimated $157K.
  • Highbridge Capital Management first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 10 quarters.
  • Highbridge Capital Management's AMAG Pharmaceuticals position peaked at $22.2M in Q2 2015.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2018.

Based on Highbridge Capital Management's 13F filing for Q1 2018, filed 15 May 2018.